Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Resverlogix : IIROC Trading Halt - RVX

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:32pm CEST

TORONTO, Oct. 13, 2017 /CNW/ - The following issues have been halted by IIROC:

Company: Resverlogix Corp.

TSX Symbol: RVX (all issues)

Reason: Pending News

Halt Time (ET): 9:16: AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
06/19RESVERLOGIX : Announces fda confirmation regarding filing pathway for apabetalon..
AQ
06/14RESVERLOGIX : Data from Resverlogix Advance Knowledge in Kidney Disease (Benefit..
AQ
06/14RESVERLOGIX : Announces FDA Confirmation Regarding Filing Pathway for Apabetalon..
GL
06/14RESVERLOGIX : Announces FDA Confirmation Regarding Filing Pathway for Apabetalon..
AQ
06/13RESVERLOGIX : Announces withdrawal of public offering of units
AQ
06/12RESVERLOGIX : Highlights potential to develop apabetalone as a therapeutic for h..
AQ
06/09RESVERLOGIX : Announces Withdrawal of Public Offering of Units
AQ
06/08RESVERLOGIX : Highlights Potential to Develop Apabetalone as a Therapeutic for H..
AQ
06/07Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for ..
GL
06/07RESVERLOGIX : Highlights Potential to Develop Apabetalone as a Therapeutic for H..
GL
More news
News from SeekingAlpha
06/16YOUR DAILY PHARMA SCOOP : Resverlogix Cleared For Trial, ViiV Positive Data, Eli.. 
06/14FDA on board with Resverlogix BETonMACE study 
05/03Resverlogix (RVXCF) Presents At 2018 Bloom Burton & Co. Healthcare Investor C.. 
04/12TSX extends review of Resverlogix's compliance with listing requirements 
04/11Resverlogix announces US$30M loan commitment letter 
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Technical analysis trends RESVERLOGIX CORP.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 8,55  CAD
Spread / Average Target 259%
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.16.10%326
CELLTRION, INC.--.--%34 574
IQVIA HOLDINGS INC8.22%21 638
LONZA GROUP1.10%20 183
INCYTE CORPORATION-23.96%15 266
ALNYLAM PHARMACEUTICALS, INC.-17.65%10 678